Walleye Trading LLC Buys 15,969 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Walleye Trading LLC increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 159.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,969 shares of the company’s stock after acquiring an additional 15,969 shares during the period. Walleye Trading LLC’s holdings in Option Care Health were worth $602,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health in the fourth quarter valued at about $26,000. UMB Bank n.a. increased its holdings in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares during the period. Signaturefd LLC raised its position in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its position in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Sterling Capital Management LLC lifted its holdings in Option Care Health by 638.5% in the 4th quarter. Sterling Capital Management LLC now owns 2,954 shares of the company’s stock worth $69,000 after buying an additional 2,554 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

Option Care Health stock opened at $32.09 on Friday. The stock’s 50 day moving average is $33.33 and its 200 day moving average is $28.65. The company has a market capitalization of $5.27 billion, a P/E ratio of 26.96, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research boosted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, JMP Securities reissued a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $33.00.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.